Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced advancements to its unified AI framework for drug target discovery, ...

Understanding drug resistance is crucial. Quantum modeling offers insights into molecular interactions, enhancing drug ...

The field of pharmacophore modeling has steadily emerged as a cornerstone in the rational design of kinase inhibitors. By abstracting the essential molecular features required for optimal binding to ...

The UK‑led OpenBind initiative has reached a major milestone with the release of its first publicly available dataset , a ...

Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...